# Nodal Therapeutics, Inc. — Form D/A

Nodal Therapeutics, Inc. of SILVER SPRING, MD, a company, filed a Form D amendment with the SEC on 2024-10-29. The offering totals $250K, of which $250K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2024-10-29
- Form: D/A
- Accession: 0002024197-24-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $250K
- Amount sold: $250K
- Investors: 1
- Date of first sale: 2024-05-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-515359

## Issuer

- Name: Nodal Therapeutics, Inc.
- CIK: 0002024197
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 1804 EDGEWATER PARKWAY, SILVER SPRING, MD, 20903
- Phone: 608-215-5779

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Christopher Jewell | Director | Silver Spring, MD |
| Jonathan S Bromberg | Executive Officer | Silver Spring, MD |
| Christopher Jewell | Executive Officer | Silver Spring, MD |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-06-06](https://search.stillhousedata.com/formd/0002024197-24-000001) | D | $100K | $100K |

## More

- [CIK 2024197 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2024197&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002024197-24-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.